Mark D. Watanabe

537 total citations
11 papers, 414 citations indexed

About

Mark D. Watanabe is a scholar working on Psychiatry and Mental health, Molecular Biology and Pharmacology. According to data from OpenAlex, Mark D. Watanabe has authored 11 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Psychiatry and Mental health, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Mark D. Watanabe's work include Schizophrenia research and treatment (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 paper) and Gastroesophageal reflux and treatments (1 paper). Mark D. Watanabe is often cited by papers focused on Schizophrenia research and treatment (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 paper) and Gastroesophageal reflux and treatments (1 paper). Mark D. Watanabe collaborates with scholars based in United States. Mark D. Watanabe's co-authors include John M. Davis, Lesley M. Blake, Stephen R. Saklad, Chester M. Davis, Michael W. Jann, Larry Ereshefsky, Daniel M. Laskin, Eileen Martin, Ovidio A. De León and Allan Brodie and has published in prestigious journals such as Drugs, Photochemistry and Photobiology and Journal of Clinical Psychopharmacology.

In The Last Decade

Mark D. Watanabe

11 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Watanabe United States	7	252	84	66	60	50	11	414
S. Heylen Belgium	7	452 1.8×	94 1.1×	96 1.5×	97 1.6×	40 0.8×	11	560
Julie Cole United States	12	335 1.3×	102 1.2×	43 0.7×	97 1.6×	26 0.5×	17	611
Sheila Assunção-Talbott United States	8	308 1.2×	72 0.9×	44 0.7×	57 0.9×	22 0.4×	9	367
C.G.G. Link United Kingdom	8	500 2.0×	79 0.9×	80 1.2×	143 2.4×	19 0.4×	14	585
Maxim V. Cheine Finland	7	384 1.5×	97 1.2×	134 2.0×	64 1.1×	26 0.5×	8	447
Doron Mazeh Israel	16	326 1.3×	86 1.0×	42 0.6×	89 1.5×	35 0.7×	21	544
Marc Eneman Belgium	5	235 0.9×	73 0.9×	77 1.2×	51 0.8×	14 0.3×	12	313
Angela Hill United States	10	235 0.9×	113 1.3×	38 0.6×	50 0.8×	20 0.4×	21	422
Yasuo Fujii Japan	11	326 1.3×	118 1.4×	48 0.7×	53 0.9×	44 0.9×	26	468
Д. Набер Germany	10	250 1.0×	83 1.0×	58 0.9×	41 0.7×	31 0.6×	26	398

Countries citing papers authored by Mark D. Watanabe

Since Specialization

Citations

This map shows the geographic impact of Mark D. Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Watanabe more than expected).

Fields of papers citing papers by Mark D. Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Watanabe. The network helps show where Mark D. Watanabe may publish in the future.

Co-authorship network of co-authors of Mark D. Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Watanabe. A scholar is included among the top collaborators of Mark D. Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Watanabe. Mark D. Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

DiVall, Margarita V., et al.. (2013). Student perceptions about developing an evidence-based public health program directed toward a vulnerable population. Currents in Pharmacy Teaching and Learning. 5(2). 76–84. 3 indexed citations

Semla, Todd P. & Mark D. Watanabe. (1998). ASHP Therapeutic Position Statement on the Recognition and Treatment of Depression in Older Adults. American Journal of Health-System Pharmacy. 55(23). 2514–2518. 12 indexed citations

Sharma, Rajiv P., et al.. (1997). Acute Dietary Tryptophan Depletion: Effects on Schizophrenic Positive and Negative Symptoms. Neuropsychobiology. 35(1). 5–10. 27 indexed citations

Hartman, Tim olde & Mark D. Watanabe. (1996). Pharmacotherapy of Depression: Focused Considerations for Primary Care. Journal of the American Pharmaceutical Association (1996). 36(8). 521–533. 3 indexed citations

Watanabe, Mark D., et al.. (1995). Successful methylphenidate treatment of apathy after subcortical infarcts. Journal of Neuropsychiatry. 7(4). 502–504. 40 indexed citations

Davis, John M., et al.. (1994). Depot Antipsychotic Drugs. Drugs. 47(5). 741–773. 231 indexed citations

Watanabe, Mark D., et al.. (1994). A toolset for systematic observation and evaluation of computer-human interaction. 5–6. 2 indexed citations

Ereshefsky, Larry, Stephen R. Saklad, Mark D. Watanabe, Chester M. Davis, & Michael W. Jann. (1991). Thiothixene Pharmacokinetic Interactions. Journal of Clinical Psychopharmacology. 11(5). 296???301–296???301. 46 indexed citations

Watanabe, Mark D. & John M. Davis. (1990). Overview: Pharmacotherapeutic Considerations in the Elderly Psychiatric Patient. Psychiatric Annals. 20(8). 423–432. 2 indexed citations

10.

Shetlar, Martin D., et al.. (1984). PHOTOCHEMICAL ADDITION OF AMINO ACIDS AND PEPTIDES TO HOMOPOLYRIBONUCLEOTIDES OF THE MAJOR DNA BASES. Photochemistry and Photobiology. 39(2). 135–140. 26 indexed citations

11.

Watanabe, Mark D., Daniel M. Laskin, & Allan Brodie. (1957). The effect of autotransplantation on growth of the zygomatico‐maxillary suture. American Journal of Anatomy. 100(3). 319–335. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact